Skip to content

Immediate effect of acupuncture at "San Feng acupoints" on patients with posterior circulation ischemia vertigo: A randomized sham-controlled clinical trial

Observation on the immediate and clinical effects of acupuncture at "San Feng acupoints" on patients with posterior circulation ischemia vertigo

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005551
Enrollment
Unknown
Registered
2022-01-21
Start date
2022-02-10
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

posterior circulation ischemia vertigo

Interventions

Acupuncture group:Acupuncture at "San Feng acupoints"
Sham acupuncture group:Sham acupuncture at "San Feng acupoints"

Sponsors

Shenzhen Hospital, Shanghai University of Traditional Chinese Medicine (Shenzhen Luohu Hospital of Traditional Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Patients 40-75 years old, regardless of sex who; 2) meet the Western medicine diagnostic criteria for PCIV in combination with imaging findings and clinical symptoms and are 3) clear-minded and able to cooperate with the requirements and complete the various assessments, and 4) can provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients with vertigo caused by intracranial space-occupying lesions, stroke, brain trauma, eye and ear diseases such as Meniere's disease, labyrinthitis, vestibular neuritis, streptomycin poisoning, and other diseases confirmed by examination; 2) patients with symptoms and signs of large-area severe cerebral infarction such as cerebellar or brainstem infarction; 3) patients with serious heart, lung, liver, kidney diseases, and mental diseases; 4) pregnant or lactating women, or patients with allergies; and 5) patients who have acupuncture treatment in recent months.

Design outcomes

Primary

MeasureTime frame
Evaluation criteria for clinical efficacy of ultrasonography;Transcranial Doppler sonography (TCD);Dizziness Assessment Rating Scale (DARS);

Countries

China

Contacts

Public ContactHai Huang
haichuan880@163.com15216679832

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026